Global Antiseptics and Disinfectants Market Size

Antiseptics and Disinfectants Market Analysis

The antiseptics and disinfectants market is expected to register a CAGR of 5.5% during the forecast period.

Due to their antiviral qualities against severe acute respiratory syndrome, the use of antiseptic medications and disinfectants has significantly increased during 2020 in a variety of medical and occupational settings, in trade and gastronomy, as well as in the home during the pandemic. Common disinfectants that have been approved for use against COVID-19 viruses typically contain chemicals like quaternary ammonium compounds (QACs), hydrogen peroxide, bleach (sodium hypochlorite), and alcohol as active components. In August 2020, FMCG major Marico announced the launch of Protect range of surface disinfectant sprays, strengthening its portfolio into the fast-growing segment of safety and hygiene after Covid-19. Similarly, in March 2020, the United States Environmental Protection Agency (EPA) released a list of EPA-registered disinfectant products that have qualified for use against SARS-CoV-2, the novel coronavirus that causes COVID-19.

The antiseptics and disinfectants market is expected to rise due to the rising incidence of hospital-acquired infections, the growing geriatric population, the subsequent growth in the prevalence of chronic diseases, and an increasing number of surgical procedures. Infections acquired in hospitals may result in an increase in cost, hospital stay, and morbidity. For instance, STERIS bought Cantel Medical Corporation through a United States subsidiary in January 2021. Cantel is a leading supplier of equipment and services for infection control with a focus on the dentistry and endoscopic markets. Consequently, it is anticipated that this will stimulate market expansion. According to World Health Organization (WHO) data updated in 2022, globally, hundreds of millions of people every year are affected by healthcare-associated cited infections (HAIs), many of which are completely avoidable. 48.7% of sepsis with organ dysfunction treated in adult ICUs are hospital-acquired. Mortality among patients with affected healthcare-associated sepsis was 24.4%, with an increase to 52.3% among patients treated in ICU. This is expected to increase the market growth.

The growing geriatric population is also prone to many infections due to weak immune systems in the aging population. For instance, according to World Health Organization (WHO) key facts updated in October 2021, the proportion of the world's population over 60 years will nearly double from 12% to 22% and by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years. Globally, people are living longer. Most people may anticipate living into their 60s and beyond. The number of older people and their share of the population is increasing in every nation on earth. One in six individuals on the planet will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons in the globe who are 60 years or older will double by 2050. Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. Thus, the rising aging population is expected to have a weak immune system and acquire more and more infections. To reduce such infections many antiseptics and disinfectants are used and thereby expected to drive the market.